First patients sought for new targeted cancer pill trial
Disease control
Not yet recruiting
This is the first study in people to test a new oral drug called D3S-003. It is for adults with advanced solid tumors that have a specific genetic change called KRAS G12D and have stopped responding to standard treatments. The main goals are to find a safe dose, see how the body …
Phase: PHASE1 • Sponsor: D3 Bio (Wuxi) Co., Ltd • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC